Partner
Columns
Title | Category | Published |
---|---|---|
‘The award for most memorable drug approval goes to…’ | Jul. 26, 2021 | |
FDA proposes rule clarifying evidence for determining product’s intended use | Administrative/Regulatory | Nov. 2, 2020 |
EO to ensure drug rebates are passed down to patients | Administrative/Regulatory, Health Care & Hospital Law | Sep. 15, 2020 |
The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
Bill would bring drugs that treat serious conditions to market faster | Health Care & Hospital Law | Jun. 16, 2020 |
FDA, FTC issue joint statement on efforts to support market for biologics | Administrative/Regulatory, Health Care & Hospital Law | Feb. 24, 2020 |
For hemp, skipping proposed rule stage could create problems | Administrative/Regulatory | May 16, 2019 |
23andMe green light is a shift for FDA | May 1, 2017 |
MCLE
Title | Category | Published |
---|---|---|
The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
Title | Category | Published |
---|---|---|
‘The award for most memorable drug approval goes to…’ | Jul. 26, 2021 | |
FDA proposes rule clarifying evidence for determining product’s intended use | Administrative/Regulatory | Nov. 2, 2020 |
EO to ensure drug rebates are passed down to patients | Administrative/Regulatory, Health Care & Hospital Law | Sep. 15, 2020 |
The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
Bill would bring drugs that treat serious conditions to market faster | Health Care & Hospital Law | Jun. 16, 2020 |
FDA, FTC issue joint statement on efforts to support market for biologics | Administrative/Regulatory, Health Care & Hospital Law | Feb. 24, 2020 |
For hemp, skipping proposed rule stage could create problems | Administrative/Regulatory | May 16, 2019 |
23andMe green light is a shift for FDA | May 1, 2017 |
Title | Category | Published |
---|---|---|
The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |